Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EOLS – Evolent Health Inc.

Evolus, Inc. Common Stock
EOLS
$6.70
Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $441,226,816.00
EPSttm : -0.66
finviz dynamic chart for EOLS
Evolus, Inc. Common Stock
$6.70
0.30%
$0.02
EOLS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

11.12

Margin Of Safety %

Put/Call OI Ratio

0.34

EPS Next Q Diff

0.09

EPS Last/This Y

0.71

EPS This/Next Y

0.36

Price

6.7

Target Price

14.67

Analyst Recom

1.29

Performance Q

26.89

Upside

-450.0%

Beta

1.32

Ticker: EOLS




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11EOLS6.320.300.4314424
2026-05-12EOLS6.510.300.0014427
2026-05-13EOLS6.720.300.0014437
2026-05-14EOLS6.590.290.0014792
2026-05-15EOLS6.490.290.0014799
2026-05-18EOLS6.580.340.0012760
2026-05-19EOLS6.430.340.0012723
2026-05-20EOLS6.580.340.0012746
2026-05-21EOLS6.440.330.0012781
2026-05-22EOLS6.080.330.4412794
2026-05-26EOLS6.260.330.0012789
2026-05-27EOLS6.190.340.0012675
2026-05-28EOLS6.570.340.1912610
2026-05-29EOLS6.570.340.0212660
2026-06-02EOLS6.180.340.3112757
2026-06-03EOLS6.030.340.0012756
2026-06-04EOLS6.590.340.0012742
2026-06-05EOLS6.740.340.0012795
2026-06-08EOLS6.680.340.0012795
2026-06-09EOLS6.690.340.0412773
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11EOLS6.3280.512.0-0.12
2026-05-12EOLS6.5176.610.4-0.12
2026-05-13EOLS6.7276.610.4-0.12
2026-05-14EOLS6.5976.610.9-0.12
2026-05-15EOLS6.4976.610.9-0.12
2026-05-18EOLS6.5776.610.6-0.12
2026-05-19EOLS6.4376.610.9-0.12
2026-05-20EOLS6.5976.610.5-0.12
2026-05-21EOLS6.4476.611.0-0.12
2026-05-22EOLS6.0883.411.3-0.09
2026-05-26EOLS6.2683.410.5-0.09
2026-05-27EOLS6.1883.410.9-0.09
2026-05-28EOLS6.5783.410.1-0.09
2026-05-29EOLS6.5783.410.8-0.09
2026-06-01EOLS6.5383.410.8-0.09
2026-06-02EOLS6.1883.411.3-0.09
2026-06-03EOLS6.0383.411.0-0.09
2026-06-04EOLS6.5983.49.9-0.09
2026-06-05EOLS6.6883.410.6-0.09
2026-06-08EOLS6.6883.410.8-0.09
2026-06-09EOLS6.7083.410.7-0.09
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11EOLS-1.00-8.1813.66
2026-05-12EOLS-1.00-8.1813.75
2026-05-13EOLS-1.00-8.1813.75
2026-05-14EOLS-1.00-8.1813.75
2026-05-15EOLS-1.00-8.1813.75
2026-05-18EOLS-1.00-7.3813.75
2026-05-19EOLS-1.00-7.3813.75
2026-05-20EOLS-1.00-7.3813.75
2026-05-21EOLS-1.00-7.3813.75
2026-05-22EOLS-1.00-7.3813.75
2026-05-26EOLS-1.00-6.8111.99
2026-05-27EOLS-1.68-6.8111.99
2026-05-28EOLS-1.68-6.8111.12
2026-05-29EOLS-1.68-6.8111.12
2026-06-02EOLS-1.68-7.4711.12
2026-06-03EOLS-1.68-7.4711.12
2026-06-04EOLS-1.68-7.4711.12
2026-06-05EOLS-1.68-7.4711.12
2026-06-08EOLS-1.68-7.4711.12
2026-06-09EOLS-1.68-7.4711.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

-1.68

Institutional Transactions

-7.47

Beta

1.32

Average Sales Estimate Current Quarter

81

Average Sales Estimate Next Quarter

78

Fair Value

Quality Score

36

Growth Score

47

Sentiment Score

54

Actual DrawDown %

62.4

Max Drawdown 5-Year %

-77.5

Target Price

14.67

P/E

Forward P/E

25.12

PEG

P/S

1.46

P/B

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-0.09

EPS Next Y. (Est.)

0.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.39

Relative Volume

0.88

Return on Equity vs Sector %

123.4

Return on Equity vs Industry %

142.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

10.7
EOLS Healthcare
$6.70
📉
Swing / Pullback
Buy the dip on strong trends
50 /100
WEAK
Trend
8/20
Pullback
10/25
Volume
7/15
Valuation
15/20
TP/AR
2/10
Options
8/10
RSI
61.4
Range 1M
80.2%
Sup Dist
1.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
42 /100
WEAK
Momentum
6/25
Growth
24/30
Estimates
1/20
Inst/Vol
3/15
Options
8/10
EPS Yr
78.6%
EPS NY
384.4%
52W%
42.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +63.3% upside
Quality
7/30
Valuation
14/30
Growth
16/25
Stability
7/10
LT Trend
4/5
Upside
+63.3%
Quality
36
Evolus, Inc. Common Stock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 350
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
EOLS

Latest News

Caricamento notizie per EOLS
stock quote shares EOLS – Evolent Health Inc. Stock Price stock today
news today EOLS – Evolent Health Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolent Health Inc. yahoo finance google finance
stock history EOLS – Evolent Health Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading

EOLS – Evolus, Inc.

Evolus, Inc. Common Stock
EOLS
$6.70
Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $441,226,816.00
EPSttm : -0.66
finviz dynamic chart for EOLS
Evolus, Inc. Common Stock
$6.70
0.30%
$0.02
EOLS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

11.12

Margin Of Safety %

Put/Call OI Ratio

0.34

EPS Next Q Diff

0.09

EPS Last/This Y

0.71

EPS This/Next Y

0.36

Price

6.7

Target Price

14.67

Analyst Recom

1.29

Performance Q

26.89

Upside

-450.0%

Beta

1.32

Ticker: EOLS




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11EOLS6.320.300.4314424
2026-05-12EOLS6.510.300.0014427
2026-05-13EOLS6.720.300.0014437
2026-05-14EOLS6.590.290.0014792
2026-05-15EOLS6.490.290.0014799
2026-05-18EOLS6.580.340.0012760
2026-05-19EOLS6.430.340.0012723
2026-05-20EOLS6.580.340.0012746
2026-05-21EOLS6.440.330.0012781
2026-05-22EOLS6.080.330.4412794
2026-05-26EOLS6.260.330.0012789
2026-05-27EOLS6.190.340.0012675
2026-05-28EOLS6.570.340.1912610
2026-05-29EOLS6.570.340.0212660
2026-06-02EOLS6.180.340.3112757
2026-06-03EOLS6.030.340.0012756
2026-06-04EOLS6.590.340.0012742
2026-06-05EOLS6.740.340.0012795
2026-06-08EOLS6.680.340.0012795
2026-06-09EOLS6.690.340.0412773
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11EOLS6.3280.512.0-0.12
2026-05-12EOLS6.5176.610.4-0.12
2026-05-13EOLS6.7276.610.4-0.12
2026-05-14EOLS6.5976.610.9-0.12
2026-05-15EOLS6.4976.610.9-0.12
2026-05-18EOLS6.5776.610.6-0.12
2026-05-19EOLS6.4376.610.9-0.12
2026-05-20EOLS6.5976.610.5-0.12
2026-05-21EOLS6.4476.611.0-0.12
2026-05-22EOLS6.0883.411.3-0.09
2026-05-26EOLS6.2683.410.5-0.09
2026-05-27EOLS6.1883.410.9-0.09
2026-05-28EOLS6.5783.410.1-0.09
2026-05-29EOLS6.5783.410.8-0.09
2026-06-01EOLS6.5383.410.8-0.09
2026-06-02EOLS6.1883.411.3-0.09
2026-06-03EOLS6.0383.411.0-0.09
2026-06-04EOLS6.5983.49.9-0.09
2026-06-05EOLS6.6883.410.6-0.09
2026-06-08EOLS6.6883.410.8-0.09
2026-06-09EOLS6.7083.410.7-0.09
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11EOLS-1.00-8.1813.66
2026-05-12EOLS-1.00-8.1813.75
2026-05-13EOLS-1.00-8.1813.75
2026-05-14EOLS-1.00-8.1813.75
2026-05-15EOLS-1.00-8.1813.75
2026-05-18EOLS-1.00-7.3813.75
2026-05-19EOLS-1.00-7.3813.75
2026-05-20EOLS-1.00-7.3813.75
2026-05-21EOLS-1.00-7.3813.75
2026-05-22EOLS-1.00-7.3813.75
2026-05-26EOLS-1.00-6.8111.99
2026-05-27EOLS-1.68-6.8111.99
2026-05-28EOLS-1.68-6.8111.12
2026-05-29EOLS-1.68-6.8111.12
2026-06-02EOLS-1.68-7.4711.12
2026-06-03EOLS-1.68-7.4711.12
2026-06-04EOLS-1.68-7.4711.12
2026-06-05EOLS-1.68-7.4711.12
2026-06-08EOLS-1.68-7.4711.12
2026-06-09EOLS-1.68-7.4711.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

-1.68

Institutional Transactions

-7.47

Beta

1.32

Average Sales Estimate Current Quarter

81

Average Sales Estimate Next Quarter

78

Fair Value

Quality Score

36

Growth Score

47

Sentiment Score

54

Actual DrawDown %

62.4

Max Drawdown 5-Year %

-77.5

Target Price

14.67

P/E

Forward P/E

25.12

PEG

P/S

1.46

P/B

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-0.09

EPS Next Y. (Est.)

0.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.39

Relative Volume

0.88

Return on Equity vs Sector %

123.4

Return on Equity vs Industry %

142.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

10.7
EOLS Healthcare
$6.70
📉
Swing / Pullback
Buy the dip on strong trends
50 /100
WEAK
Trend
8/20
Pullback
10/25
Volume
7/15
Valuation
15/20
TP/AR
2/10
Options
8/10
RSI
61.4
Range 1M
80.2%
Sup Dist
1.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
42 /100
WEAK
Momentum
6/25
Growth
24/30
Estimates
1/20
Inst/Vol
3/15
Options
8/10
EPS Yr
78.6%
EPS NY
384.4%
52W%
42.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +63.3% upside
Quality
7/30
Valuation
14/30
Growth
16/25
Stability
7/10
LT Trend
4/5
Upside
+63.3%
Quality
36
Evolus, Inc. Common Stock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 350
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
EOLS

Latest News

Caricamento notizie per EOLS
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading